A detailed history of Haverford Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Haverford Trust CO holds 26,778 shares of NVO stock, worth $2.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,778
Previous 27,438 2.41%
Holding current value
$2.34 Million
Previous $3.92 Million 18.59%
% of portfolio
0.03%
Previous 0.04%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$119.07 - $145.42 $78,586 - $95,977
-660 Reduced 2.41%
26,778 $3.19 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $144,552 - $173,059
1,178 Added 4.49%
27,438 $3.92 Million
Q4 2023

Feb 08, 2024

SELL
$87.78 - $105.45 $124,823 - $149,949
-1,422 Reduced 5.14%
26,260 $2.72 Million
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $1.26 Million - $2.76 Million
13,816 Added 99.64%
27,682 $2.52 Million
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $33,379 - $36,947
214 Added 1.57%
13,866 $2.24 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $157,749 - $189,694
1,192 Added 9.57%
13,652 $2.17 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $47,640 - $58,465
500 Added 4.18%
12,460 $1.24 Million
Q2 2022

Aug 12, 2022

SELL
$103.24 - $121.81 $2,993 - $3,532
-29 Reduced 0.24%
11,960 $1.33 Million
Q1 2022

May 05, 2022

SELL
$93.1 - $112.54 $3,537 - $4,276
-38 Reduced 0.32%
11,989 $1.33 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $3,643 - $4,449
38 Added 0.32%
12,027 $1.35 Million
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $2,448 - $3,091
29 Added 0.24%
11,989 $1.15 Million
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $741,418 - $928,800
10,958 Added 1093.61%
11,960 $1 Million
Q2 2021

Aug 16, 2021

SELL
$67.66 - $84.76 $608,804 - $762,670
-8,998 Reduced 89.98%
1,002 $1 Million
Q4 2020

Feb 05, 2021

SELL
$63.89 - $73.8 $53,348 - $61,623
-835 Reduced 7.71%
10,000 $699,000
Q3 2020

Nov 10, 2020

SELL
$63.69 - $70.22 $1,847 - $2,036
-29 Reduced 0.27%
10,835 $752,000
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $936 - $1,087
-16 Reduced 0.15%
10,864 $711,000
Q1 2020

May 11, 2020

SELL
$49.46 - $64.78 $37,737 - $49,427
-763 Reduced 6.55%
10,880 $655,000
Q4 2019

Feb 10, 2020

BUY
$49.86 - $58.26 $16,653 - $19,458
334 Added 2.95%
11,643 $674,000
Q3 2019

Nov 04, 2019

BUY
$47.54 - $53.43 $6,322 - $7,106
133 Added 1.19%
11,309 $585,000
Q2 2019

Aug 13, 2019

SELL
$46.79 - $52.47 $8,188 - $9,182
-175 Reduced 1.54%
11,176 $570,000
Q1 2019

May 09, 2019

BUY
$46.36 - $52.63 $20,676 - $23,472
446 Added 4.09%
11,351 $594,000
Q3 2018

Nov 08, 2018

SELL
$46.76 - $51.24 $11,175 - $12,246
-239 Reduced 2.14%
10,905 $514,000
Q2 2018

Aug 10, 2018

SELL
$44.29 - $50.42 $5,270 - $5,999
-119 Reduced 1.06%
11,144 $514,000
Q1 2018

May 09, 2018

BUY
$48.49 - $58.14 $11,589 - $13,895
239 Added 2.17%
11,263 $555,000
Q4 2017

Feb 13, 2018

SELL
$47.53 - $53.73 $34,459 - $38,954
-725 Reduced 6.17%
11,024 $592,000
Q3 2017

Nov 09, 2017

BUY
$41.15 - $49.22 $10,287 - $12,305
250 Added 2.17%
11,749 $566,000
Q2 2017

Aug 14, 2017

BUY
N/A
11,499
11,499 $493,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Haverford Trust CO Portfolio

Follow Haverford Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.